Coloplast Pre-Tax Profit Margin 2014-2025 | CLPBY
Current and historical pre-tax profit margin for Coloplast (CLPBY) from 2014 to 2025. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue. Coloplast pre-tax profit margin for the three months ending September 30, 2025 was .
| Coloplast Pre-Tax Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
| 2025-09-30 | $4.13B | $0.91B | 22.09% |
| 2025-06-30 | $4.06B | $0.90B | 22.22% |
| 2025-03-31 | $4.00B | $0.93B | 23.35% |
| 2024-12-31 | $3.98B | $0.96B | 24.06% |
| 2024-09-30 | $3.93B | $0.93B | 23.63% |
| 2024-06-30 | $3.82B | $0.92B | 23.98% |
| 2024-03-31 | $3.71B | $0.92B | 24.64% |
| 2023-12-31 | $3.63B | $0.89B | 24.59% |
| 2023-09-30 | $3.51B | $0.86B | 24.60% |
| 2023-06-30 | $3.43B | $0.86B | 25.13% |
| 2023-03-31 | $3.38B | $0.87B | 25.67% |
| 2022-12-31 | $3.34B | $0.85B | 25.49% |
| 2022-09-30 | $3.29B | $0.89B | 27.13% |
| 2022-06-30 | $3.27B | $0.93B | 28.52% |
| 2022-03-31 | $3.22B | $0.96B | 29.70% |
| 2021-12-31 | $3.16B | $1.00B | 31.69% |
| 2021-09-30 | $3.12B | $1.00B | 32.06% |
| 2021-06-30 | $3.04B | $0.96B | 31.49% |
| 2021-03-31 | $2.91B | $0.89B | 30.46% |
| 2020-12-31 | $2.85B | $0.85B | 29.89% |
| 2020-09-30 | $2.79B | $0.82B | 29.48% |
| 2020-06-30 | $2.75B | $0.76B | 27.56% |
| 2020-03-31 | $2.79B | $0.78B | 27.81% |
| 2019-12-31 | $2.75B | $0.77B | 28.13% |
| 2019-09-30 | $2.71B | $0.76B | 28.03% |
| 2019-06-30 | $2.69B | $0.82B | 30.61% |
| 2019-03-31 | $2.67B | $0.81B | 30.36% |
| 2018-12-31 | $2.66B | $0.81B | 30.22% |
| 2018-09-30 | $2.63B | $0.80B | 30.49% |
| 2018-06-30 | $2.59B | $0.80B | 30.69% |
| 2018-03-31 | $2.50B | $0.77B | 31.00% |
| 2017-12-31 | $2.39B | $0.75B | 31.41% |
| 2017-09-30 | $2.31B | $0.74B | 31.85% |
| 2017-03-31 | $1.64B | $0.89B | 54.21% |
| 2016-12-31 | $1.50B | $1.14B | 75.62% |
| 2015-12-31 | $2.07B | $2.07B | 100.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $17.601B | $4.130B |
| Coloplast A/S engages in the development and sale of intimate healthcare products and services principally in Denmark, the United States, the United Kingdom, France and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology and Advanced Wound Care segments. Coloplast A/S is based in Humleb?k, Denmark. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $203.946B | 23.74 |
| Intuitive Surgical (ISRG) | United States | $173.357B | 66.87 |
| IDEXX Laboratories (IDXX) | United States | $51.473B | 49.32 |
| Edwards Lifesciences (EW) | United States | $45.675B | 30.63 |
| Alcon (ALC) | Switzerland | $38.991B | 26.28 |
| IQVIA Holdings (IQV) | United States | $31.930B | 17.25 |
| Mettler-Toledo (MTD) | United States | $28.060B | 32.10 |
| DexCom (DXCM) | United States | $27.289B | 37.62 |
| STERIS (STE) | Ireland | $24.749B | 25.02 |
| Waters (WAT) | United States | $22.705B | 30.02 |
| Hologic (HOLX) | United States | $16.701B | 17.48 |
| SONOVA HOLDING (SONVY) | Switzerland | $15.912B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.959B | 11.58 |
| Penumbra (PEN) | United States | $13.355B | 93.94 |
| Globus Medical (GMED) | United States | $11.752B | 24.67 |
| SARTORIUS (SSSGY) | Germany | $7.976B | 46.32 |
| Masimo (MASI) | United States | $7.474B | 23.95 |
| Glaukos (GKOS) | United States | $6.463B | 0.00 |
| Sysmex ADR (SSMXY) | Japan | $6.024B | 19.14 |
| Teleflex (TFX) | United States | $4.792B | 7.64 |
| TransMedics (TMDX) | United States | $4.616B | 54.68 |
| LivaNova (LIVN) | United Kingdom | $3.635B | 19.63 |
| Integer Holdings (ITGR) | United States | $3.029B | 14.22 |
| Veracyte (VCYT) | United States | $2.861B | 32.60 |
| Elekta AB (EKTAY) | Sweden | $2.241B | 20.97 |
| UFP Technologies (UFPT) | United States | $2.062B | 27.22 |
| Alphatec Holdings (ATEC) | United States | $2.053B | 0.00 |
| Artivion (AORT) | United States | $1.876B | 86.07 |
| Nihon Kohden (NHNKY) | Japan | $1.855B | 20.47 |
| AxoGen (AXGN) | United States | $1.611B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $1.606B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.406B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.300B | 0.00 |
| IRadimed (IRMD) | United States | $1.221B | 58.16 |
| OPKO Health (OPK) | United States | $0.952B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.877B | 4.75 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.677B | 13.51 |
| SiBone (SIBN) | United States | $0.676B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.623B | 36.25 |
| Alpha Tau Medical (DRTS) | Israel | $0.603B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.576B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.549B | 0.00 |
| NeuroPace (NPCE) | United States | $0.522B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.515B | 13.42 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.507B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.435B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.418B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.383B | 0.00 |
| RxSight (RXST) | United States | $0.345B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.331B | 55.12 |
| Semler Scientific (SMLR) | United States | $0.311B | 2.32 |
| Sight Sciences (SGHT) | United States | $0.310B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.283B | 0.00 |
| 908 Devices (MASS) | United States | $0.237B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.226B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.177B | 0.00 |
| CVRx (CVRX) | United States | $0.172B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.172B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.168B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.160B | 0.00 |
| Inogen (INGN) | United States | $0.154B | 0.00 |
| LENSAR (LNSR) | United States | $0.144B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.144B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.118B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.118B | 0.00 |
| Hyperfine (HYPR) | United States | $0.107B | 0.00 |
| Neuronetics (STIM) | United States | $0.107B | 0.00 |
| Solana (HSDT) | United States | $0.090B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.083B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.078B | 0.00 |
| InspireMD (NSPR) | United States | $0.074B | 0.00 |
| Accuray (ARAY) | United States | $0.070B | 0.00 |
| DarioHealth (DRIO) | United States | $0.067B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.060B | 0.00 |
| Positron (POSC) | United States | $0.058B | 0.00 |
| Spectral AI (MDAI) | United States | $0.047B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.046B | 0.00 |
| Precision Optics (POCI) | United States | $0.044B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.027B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.024B | 0.00 | |
| Adagio Medical Holdings (ADGM) | United States | $0.015B | 0.00 |
| Envoy Medical (COCH) | United States | $0.014B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.013B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.012B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| NexGel (NXGL) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.007B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| ENvue Medical (FEED) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |